newsfilter
← Latest News
GlobeNewswire·

Avenue Therapeutics Announces Closing of $12 Million Underwritten Public Offering

NEW YORK, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ:ATXI) ("Avenue" or the "Company"), a specialty pharmaceutical company focused on the development and commercialization of therapies for the